ALTERATIONS IN DOPAMINE METABOLISM AFTER CHRONIC ADMINISTRATION OF HALOPERIDOL - POSSIBLE ROLE OF INCREASED AUTORECEPTOR SENSITIVITY

被引:46
作者
SALLER, CF
SALAMA, AI
机构
关键词
D O I
10.1016/0028-3908(85)90171-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:123 / 129
页数:7
相关论文
共 26 条
[1]   DOPAMINE AUTORECEPTORS - PHARMACOLOGICAL CHARACTERIZATION BY MICROIONTOPHORETIC SINGLE CELL RECORDING STUDIES [J].
AGHAJANIAN, GK ;
BUNNEY, BS .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1977, 297 (01) :1-7
[2]   TOLERANCE PHENOMENA WITH NEUROLEPTICS CATALEPSY, APOMORPHINE STEREOTYPES AND STRIATAL DOPAMINE METABOLISM IN RAT AFTER SINGLE AND REPEATED ADMINISTRATION OF LOXAPINE AND HALOPERIDOL [J].
ASPER, H ;
BAGGIOLINI, M ;
BURKI, HR ;
LAUENER, H ;
RUCH, W ;
STILLE, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1973, 22 (03) :287-294
[3]   PRESYNAPTIC DOPAMINE-RECEPTORS - INSENSITIVITY TO KAINIC ACID AND THE DEVELOPMENT OF SUPER-SENSITIVITY FOLLOWING CHRONIC HALOPERIDOL [J].
BANNON, MJ ;
BUNNEY, EB ;
ZIGUN, JR ;
SKIRBOLL, LR ;
ROTH, RH .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1980, 312 (02) :161-165
[4]   ACUTE AND CHRONIC HALOPERIDOL TREATMENT - COMPARISON OF EFFECTS ON NIGRAL DOPAMINERGIC CELL ACTIVITY [J].
BUNNEY, BS ;
GRACE, AA .
LIFE SCIENCES, 1978, 23 (16) :1715-1727
[5]   ANTI-SCHIZOPHRENIC DRUGS - CHRONIC TREATMENT ELEVATES DOPAMINE RECEPTOR-BINDING IN BRAIN [J].
BURT, DR ;
CREESE, I ;
SNYDER, SH .
SCIENCE, 1977, 196 (4287) :327-328
[6]  
CHIODO LA, 1983, J NEUROSCI, V3, P1607
[7]   POSTSYNAPTIC RECEPTORS ARE NOT ESSENTIAL FOR DOPAMINERGIC FEEDBACK REGULATION [J].
DICHIARA, G ;
PORCEDDU, ML ;
FRATTA, W ;
GESSA, GL .
NATURE, 1977, 267 (5608) :270-272
[8]   HALOPERIDOL-INDUCED PRESYNAPTIC DOPAMINE SUPER-SENSITIVITY IS BLOCKED BY CHRONIC LITHIUM [J].
GALLAGER, DW ;
PERT, A ;
BUNNEY, WE .
NATURE, 1978, 273 (5660) :309-312
[9]   FEEDBACK LOOP OR OUTPUT PATHWAY IN STRIATO-NIGRAL FIBERS [J].
GARCIAMUNOZ, M ;
NICOLAOU, NM ;
TULLOCH, IF ;
WRIGHT, AK ;
ARBUTHNOTT, GW .
NATURE, 1977, 265 (5592) :363-365
[10]  
GIANUTSOS G, 1974, BIOCHEM PHARMACOL, V24, P581